Company Filing History:
1 out of 986 
1 out of 210 
Years Active: 2023
Title: Shiro Mori: Innovator in Lymphatic Drug Delivery Systems
Introduction
Shiro Mori is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for administering anticancer drugs. His innovative approach focuses on enhancing the effectiveness of drug delivery systems.
Latest Patents
Shiro Mori holds a patent for a drug effective for lymphogenous drug administering method. This patent provides a pharmaceutical composition suitable for the administration of anticancer drugs into lymph nodes through lymphatic drug delivery systems. The composition is designed for therapeutic or prophylactic treatment of cancer and includes at least one anticancer drug selected from antimetabolites and anticancer plant alkaloids as an active ingredient. He has 1 patent to his name.
Career Highlights
Throughout his career, Shiro Mori has worked with esteemed institutions such as Tohoku University and Yakult Honsha Co., Ltd. His work has been pivotal in advancing cancer treatment methodologies, particularly through innovative drug delivery techniques.
Collaborations
Shiro Mori has collaborated with notable colleagues, including Tetsuya Kodama and Go Nohara. Their combined expertise has contributed to the development of effective pharmaceutical solutions.
Conclusion
Shiro Mori's contributions to lymphatic drug delivery systems exemplify the impact of innovation in the pharmaceutical industry. His work continues to influence cancer treatment methodologies and showcases the importance of research and collaboration in advancing medical science.